1-7 of 7
Virginia M. Klimek, M.D.
Close
Sort by
Journal Articles

High-Dose Cytarabine Monotherapy Versus Intermediate Or High-Dose Cytarabine In Combination With Other Agents As Second-Line Salvage Therapy In Patients With Acute Myeloid Leukemia Who Did Not Respond To Initial Induction Therapy

Thu Oanh T Dang, PharmD, BCOP, Patrick Hilden, MS, Sean M. Devlin, PhD, Raajit K. Rampal, M.D., Ph.D., Ross L. Levine, MD, Ellin Berman, MD, Virginia M. Klimek, M.D., Nelly G. Adel, PharmD, BCOP, BCPS, Martin S. Tallman, MD
Journal: Blood
Blood (2013) 122 (21): 2695.
https://doi.org/10.1182/blood.V122.21.2695.2695
Published: 2013
Journal Articles

Comprehensive Mutational Profiling In Myelodysplastic Syndromes Treated With Decitabine and Tretinoin

Alan H. Shih, MD PhD, Sean M. Devlin, PhD, Emily K. Dolezal, Kristina M. Knapp, BS, Kai Wang, MD PhD, Eric M. Sanford, BS, Tim Brennan, PhD, Roman Yelensky, PhD, Michelle Nahas, PhD, Geoff A Otto, PhD, Doron Lipson, PhD, Philip J Stephens, PhD, Vincent Miller, MD, Marcel R.M. van den Brink, MD, PhD, Ross L. Levine, MD, Stephen Nimer, MD, Virginia M. Klimek, M.D
Journal: Blood
Blood (2013) 122 (21): 2791.
https://doi.org/10.1182/blood.V122.21.2791.2791
Published: 2013
Journal Articles

CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes

Stephen S. Chung, MD, Wendy W Pang, Ph.D., Gino K. In, MD, Max Jan, PhD, Virginia M. Klimek, M.D., Ari Melnick, MD, Irving L. Weissman, MD, Ravi Majeti, MD, PhD, Christopher Y. Park, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 210.
https://doi.org/10.1182/blood.V120.21.210.210
Published: 2012
Journal Articles

Phase 2 Study of Decitabine in Combination with Tretinoin in Myelodysplastic Syndromes and Acute Myelogenous Leukemia: Interim Results

Virginia M. Klimek, M.D., Emily K Dolezal, Joseph G. Jurcic, MD, Sean Devlin, PhD, Kevin Zikaras, BS, Jae H. Park, MD, Todd L. Rosenblat, MD, Stephen Nimer, MD
Journal: Blood
Blood (2012) 120 (21): 3815.
https://doi.org/10.1182/blood.V120.21.3815.3815
Published: 2012
Journal Articles

Maitake Mushroom Extract in Myelodysplastic Syndrome (MDS): A Phase II Study

Kathleen M. Wesa, MD, Virginia M. Klimek, M.D., Susanna Cunningham-Rundles, PhD, Allison Hirsch, Emily K. Dolezal, Gria N Jacobs, Marci I Coleton, MA, Stephen D. Nimer, MD, Barrie R. Cassileth, PhD
Journal: Blood
Blood (2011) 118 (21): 5043.
https://doi.org/10.1182/blood.V118.21.5043.5043
Published: 2011
Journal Articles

Mutational Analysis of Therapy-Related MDS/AML

Alan H. Shih, MD, PhD, Stephen S. Chung, MD, Emily K. Dolezal, Su-Jiang Zhang, MD, Omar Abdel-Wahab, MD, Christopher Y. Park, MD, PhD, Stephen D. Nimer, MD, Ross L Levine, MD, Virginia M. Klimek, M.D.
Journal: Blood
Blood (2011) 118 (21): 2802.
https://doi.org/10.1182/blood.V118.21.2802.2802
Published: 2011
Journal Articles

Clinical Activity of DNA Methyltransferase Inhibitors In Therapy-Related Myelodysplastic Syndromes: A Retrospective Study

Michael T Tees, M.D., Emily K. Dolezal, Stephen D. Nimer, M.D., Virginia M. Klimek, M.D.
Journal: Blood
Blood (2010) 116 (21): 1891.
https://doi.org/10.1182/blood.V116.21.1891.1891
Published: 2010